Pharvaris Netherlands B.v.

This study is testing whether a new daily pill called deucrictibant can safely prevent the sudden, painful swelling attacks caused by hereditary angioedema (HAE). About 81 adolescents and adults with HAE will take either the real pill or a placebo (a dummy pill) for 24 weeks to s…

This study is testing the long-term safety and effectiveness of an oral medication called deucrictibant for treating sudden swelling attacks in people with hereditary angioedema (HAE). It will enroll about 150 adults and adolescents who have HAE and have participated in related s…